Company / Return on Assets (ROA)
IOVANCE BIOTHERAPEUTICS, INC. Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-42.8%
FY2025
5-year range
-59.6% / -40.9%
FY2021-FY2025
Trend
-4.7%
vs FY2024
Sector context
#163 of 213
Health Care
What the data says
IOVANCE BIOTHERAPEUTICS, INC.'s return on assets (roa) of -42.8% is lower than 77% of companies in the Health Care sector (FY2025). Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -59.6% in FY2022 to -7.0% in FY2016.
Based on SEC 10-K filings.
-42.8% in FY2025 with a 5-year CAGR of -9.0%.
Improved from -56.9% to -42.8% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +16.8pp
- 5-Year Change
- -9.0pp
- 10-Year Change
- -
Sector benchmark
-77.2% below sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 4.7% year-over-year.
- Currently 18.7pp below the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2016.
- Lowest return on assets (roa) in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -42.8% | -4.7% |
| FY2024 | -40.9% | +28.2% |
| FY2023 | -56.9% | +4.6% |
| FY2022 | -59.6% | -35.4% |
| FY2021 | -44.0% | -30.3% |
| FY2020 | -33.8% | +41.1% |
| FY2019 | -57.3% | -123.0% |
| FY2018 | -25.7% | +56.6% |
| FY2017 | -59.3% | -746.4% |
| FY2016 | -7.0% | +70.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026